You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chloroquin as adjuvant to standard 4-drug anti-TB therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))

Recruiting
  • Tuberculosis Infection
  • Nivaquine ® (Chloroquine)
  • Zurich, Switzerland
    Clinical Trial Center
Jun 28, 2022

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Azacitidine Injection
  • Houston, Texas
    Harris Health System - Ben Taub Hospital
Sep 1, 2022

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Tuberculosis, HIV I Infection, Sepsis Trial in Sanya Juu, Mbarara (Immediate anti-TB therapy, Sepsis-specific dose anti-TB

Recruiting
  • Tuberculosis
  • +2 more
  • Immediate anti-TB therapy
  • Sepsis-specific dose anti-TB therapy
  • Sanya Juu, Tanzania
  • +1 more
Dec 10, 2021

Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

Completed
  • Tuberculosis, MDR
  • Semey, East-Kazakhstan Region, Kazakhstan
  • +5 more
May 17, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Tuberculosis Trial in Bergen, Oslo (etoricoxib, H56:IC31)

Completed
  • Tuberculosis
  • Bergen, Norway
  • +1 more
Apr 7, 2022

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

Not yet recruiting
  • Tuberculosis
  • Human Immunodeficiency Virus
  • Optimised rifamycin
  • (no location specified)
Oct 8, 2022

In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

Not yet recruiting
  • In-stent Restenosis
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

Recruiting
  • Tuberculosis
  • +2 more
  • Observational PK study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Dec 21, 2022

Tuberculosis Trial in Kota Kinabalu (Mobile Application, Direct Observed Therapy)

Not yet recruiting
  • Tuberculosis
  • Mobile Application
  • Direct Observed Therapy
  • Kota Kinabalu, Sabah, Malaysia
    Mohd Fazeli bin Sazali
May 20, 2022

Heart Failure, Atrial Fibrillation Trial in Worldwide (Rhythm control, Rate Control)

Completed
  • Heart Failure
  • Atrial Fibrillation
  • Rhythm control
  • Rate Control
  • Porto Alegre, Rio Grande Do Sul, Brazil
  • +20 more
Oct 13, 2021

NSCLC Trial (penpulimab combined with anlotinib)

Not yet recruiting
  • NSCLC
  • penpulimab combined with anlotinib
  • (no location specified)
May 18, 2022

Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)

Not yet recruiting
  • Tuberculosis
  • Quantiferon Gold
  • +5 more
  • (no location specified)
Oct 27, 2023

Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

Not yet recruiting
  • Multi Drug Resistant Tuberculosis
  • HIV Infections
  • Adherence support intevention
  • Durban, KwaZulu-Natal, South Africa
    King DinuZulu Hospital
Nov 21, 2022

Tuberculosis Trial in Singapore (Doxycycline, Placebo)

Not yet recruiting
  • Tuberculosis
  • Singapore, Singapore
    National University Hospital
Jul 21, 2022

Melanoma Stage IIIB/C Trial in Spain, Switzerland, United States (Daromun, Surgery, Adjuvant therapy)

Recruiting
  • Melanoma Stage IIIB/C
  • La Jolla, California
  • +30 more
Dec 22, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,

Recruiting
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • +13 more
  • Scottsdale, Arizona
  • +2 more
Jun 1, 2022

Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Linezolid 600 mg
  • +7 more
  • Gaborone, South-East District, Botswana
  • +16 more
Dec 13, 2022

Huaier Granules in Postoperative Adjuvant Therapy for Non-small

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Huaier granule
  • Control
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Oct 27, 2023

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023